טוען...

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity

Aims/Introduction:  Recently, glucagon‐like peptide‐1 (GLP‐1) receptor agonists of liraglutide have become available in Japan. It has not yet been clarified what clinical parameters could discriminate liraglutide‐effective patients from liraglutide‐ineffective patients. Materials and Methods:  We re...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kozawa, Junji, Inoue, Kana, Iwamoto, Ryuya, Kurashiki, Yukiko, Okauchi, Yukiyoshi, Kashine, Susumu, Kitamura, Tetsuhiro, Maeda, Norikazu, Okita, Kohei, Iwahashi, Hiromi, Funahashi, Tohru, Imagawa, Akihisa, Shimomura, Iichiro
פורמט: Artigo
שפה:Inglês
יצא לאור: Blackwell Publishing Ltd 2012
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4014952/
https://ncbi.nlm.nih.gov/pubmed/24843579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2011.00168.x
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!